Citation Impact
Citing Papers
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology.
1999
Fatigue and health profile in sicca syndrome of Sjögren's and non-Sjögren's syndrome origin.
2001
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
1998
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
2005
John Snow's legacy: epidemiology without borders
2013 StandoutNobel
The economics of treatment in early rheumatoid arthritis
2009
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
2001 Standout
Considerations with the use of biological therapy in the treatment of rheumatoid arthritis
2004
Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial
2006
Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klotho Protein
2014 Standout
Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
2006 Standout
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
2008
Rheumatoid arthritis
2009
Sjögren's syndrome
2005 Standout
Rheumatoid arthritis
2016 Standout
The Oral Side of Sjögren Syndrome. Diagnosis and Treatment. A Review
2002
Very early treatment with infliximab in addition to methotrexate in early, poor‐prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: Results from a twelve‐month randomized, double‐blind, placebo‐controlled trial
2005
Therapeutic Strategies for Rheumatoid Arthritis
2004
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Captopril
1988
A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis
2009
The assessment of fatigue in primary Sjögren's syndrome
2003
A meta-analysis of the efficacy and toxicity of combining disease-modifying anti-rheumatic drugs in rheumatoid arthritis based on patient withdrawal
2005
The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: A longitudinal analysis
2004
Pharmacological treatment of established rheumatoid arthritis
2003
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding
2007
Osteomyelitis
1997 Standout
Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
2013
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin
2005
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
2009 Standout
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study
2006
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
2006
Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials
2012
Bacterial peptidoglycans but not CpG oligodeoxynucleotides activate synovial fibroblasts by toll‐like receptor signaling
2003
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Rheumatoid arthritis in the developing world
2003
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
2005
Very low‐dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: A multicenter, double‐blind, placebo‐controlled trial
2005
The Pathogenesis of Rheumatoid Arthritis
2011 Standout
Propionibacterium acnes: An agent of prosthetic joint infection and colonization
2007
How antirheumatic drugs protect joints from damage in rheumatoid arthritis
2008
The Role of the Vitamin D Endocrine System in Health and Disease
1989
A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
2006
Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors
2004
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
2015
Superior efficacy of combination therapy for rheumatoid arthritis: Fact or fiction?
2005
Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca
1999
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial
2014
Therapy for paraneoplastic neurologic syndromes in six patients with protein a column immunoadsorption
1995
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
2004
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)
2013
Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations
1999
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial
1999
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
2015
Hematogenous Infection of a Total Knee Arthroplasty With Klebsiella pneumoniae in Association With Occult Adenocarcinoma of the Cecum
2008
Patient Self-management of Chronic Disease in Primary Care
2002 Standout
CLINICAL COUNTERPOINT: Vitamin D: New Actions, New Analogs, New Therapeutic Potential*
1992
Joint and bone infections due to anaerobic bacteria in children
2002
Platelets and the immune continuum
2011 Standout
Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled trial
2007
A Comparative Study Between MR Sialography and Salivary Gland Scintigraphy in the Diagnosis of Sjögren Syndrome
2001
Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
2007
Technetium-99m labelled liposomes to image experimental arthritis
1997
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
2005
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial
2004
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Sarcoidosis
1997 Standout
Rheumatoid arthritis
2010 Standout
Rheumatoid arthritis
2001
Calcium and vitamin D metabolism in granulomatous diseases
1992
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Treatment of early seropositive rheumatoid arthritis: Doxycycline plus methotrexate versus methotrexate alone
2006
Therapeutic strategies for rheumatoid arthritis
2003
The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
2016 StandoutNobel
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling
2002 StandoutNobel
Cost‐utility analysis of treatment strategies in patients with recent‐onset rheumatoid arthritis
2009
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Recurrent miscarriage
2006 Standout
Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example
2014
Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: a meta-analysis
2009
The cerebellar cognitive affective syndrome
1998 Standout
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis
2008
Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis
2004
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Neurologic Manifestations in Primary Sjögren Syndrome
2004
Utility of anti‐Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy
1998
Drug Treatment for Rheumatoid Arthritis
1999
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade
2008
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
2000 Standout
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
1988 Standout
Effects of glucocorticoids on radiological progression in rheumatoid arthritis
2007
The Complex Role of Estrogens in Inflammation
2007 Standout
Computer based methods for measurement of joint space width: update of an ongoing OMERACT project.
2007
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Vitamin D-Mediated Hypercalcemia in Lymphoma: Evidence for Hormone Production by Tumor-Adjacent Macrophages
2003
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Sulfasalazine
2005
Methotrexate in Rheumatoid Arthritis
1987
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
2001 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients
2003
Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis).
2003
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents
2009
The Epitopes Targeted by the Rheumatoid Arthritis-Associated Antifilaggrin Autoantibodies are Posttranslationally Generated on Various Sites of (Pro)Filaggrin by Deimination of Arginine Residues
1999
Desiccating Stress Induces T Cell-Mediated Sjogren’s Syndrome-Like Lacrimal Keratoconjunctivitis
2006 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Glucocorticoids in rheumatoid arthritis: current status and future studies
2020
A role for fungal β-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice
2005 StandoutNobel
A comparison of randomised controlled trials in health and education
2005
Smallest detectable difference in radiological progression.
1999
In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease
2002
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Prosthetic Joint Infection
2014 Standout
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
2002
A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis.
2002
Increased uptake of 111In-octreotide in idiopathic pulmonary fibrosis.
2006
Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications for Rheumatoid Arthritis
2008
Nuclear Mediane Techniques in Septic Arthritis and Osteomyelitis
1991
Bacteroides: the Good, the Bad, and the Nitty-Gritty
2007 Standout
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis
2012
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Works of H. M. Markusse being referenced
Reduced cellularity and expression of adhesion molecules and cytokines after treatment with soluble human recombinant TNF receptor (P75) in RA patients
1999
THE DIAGNOSTIC VALUE OF SALIVARY GLAND SCINTIGRAPHY IN PATIENTS SUSPECTED OF PRIMARY SJÖGREN'S SYNDROME
1993
Infectious arthritis caused by Klebsiella. A report of two cases
1989
COBRA combination therapy in patients with early rheumatoid arthritis: Long‐term structural benefits of a brief intervention
2002
Drug points: Gynaecomastia associated with captopril
1988
Somatostatin receptor imaging. the presence of somatostatin receptors in rheumatoid arthritis
1994
The diagnostic value of salivary fluid levels of β2-microglubulin, lysozyme and lactoferrin for primary Sjögren's synrome
1992
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
1997
The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis
1996
Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis
1996
Fatigue in primary Sjögren's syndrome
1998
Infectious arthritis caused by Propionibacterium acnes: a report of two cases.
1989
Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia
1987
Involvement of the peripheral nervous system in primary Sjögren's syndrome
2001
Antineuronal antibodies in patients with neurologic complicat'lons of primary Sjogren's syndrome
1993
Beta 2 microglobulin in tear fluid from patients with primary Sjögren’s syndrome.
1992
Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients
2001
Imaging of inflammatory arthritis with technetium-99m-labeled IgG.
1989
Beta 2 microglobulin measurements in saliva of patients with primary Sjögren’s syndrome: influence of flow.
1993